Immune system regulation (4). High doses may shift tumor metabolism, reducing glycolysis (136, 137, 139). Intake inversely correlated with the risk of colorectal cancer (I) (140), bladder cancer (III) (141), and HR+/HER2-d breast cancer (II) (142). Here, ERBB2 is linked to breast carcinoma.